Clinical characteristics and treatment utilization by tumor subtype among metastatic breast cancer patients in a large US managed care health plan

被引：0
作者：
Burton, Tanya [1 ]
Byfield, Stacey DaCosta [1 ]
Fan, Ying [1 ]
Fang, Yiyu [1 ]
Cao, Feng [1 ]
Smith, Gregory L. [2 ]
Zanotti, Giovanni [2 ]
Bell, Timothy J. [2 ]
Perkins, Julia J. [2 ]
Horblyuk, Ruslan [2 ]
Teitlebaum, April
机构：
[1] Optum, New York, NY USA
[2] Pfizer, New York, NY USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P3-07-24
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-07-24
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Dyslipidemia treatment of patients with diabetes mellitus in a US managed care plan: a retrospective database analysis
    Toth, Peter P.
    Zarotsky, Victoria
    Sullivan, Jane M.
    Laitinen, Dave
    [J]. CARDIOVASCULAR DIABETOLOGY, 2009, 8
  • [42] Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer
    Danielle M. File
    Tomas Pascual
    Allison M. Deal
    Amy Wheless
    Charles M. Perou
    E. Claire Dees
    Lisa A. Carey
    [J]. Breast Cancer Research and Treatment, 2022, 196 : 153 - 162
  • [43] Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer
    File, Danielle M.
    Pascual, Tomas
    Deal, Allison M.
    Wheless, Amy
    Perou, Charles M.
    Dees, E. Claire
    Carey, Lisa A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2022, 196 (01) : 153 - 162
  • [44] Predictors of colorectal cancer screening from patients enrolled in a managed care health plan
    Farmer, Melissa M.
    Bastani, Roshan
    Kwan, Lorna
    Belman, Michael
    Ganz, Patricia A.
    [J]. CANCER, 2008, 112 (06) : 1230 - 1238
  • [45] Treatment patterns and resource utilization among patients with HR+/HER2-metastatic breast cancer in a privately insured US population
    Goyal, R. K.
    Carter, G. C.
    Nagar, S. N.
    Smyth, E. N.
    Price, G. L.
    Huang, Y-J
    Bromund, J. L.
    Li, L.
    Schilder, J. M.
    Davis, K. L.
    Kaye, J. A.
    [J]. CANCER RESEARCH, 2017, 77
  • [46] Patterns of Utilization of Imaging Studies and Serum Tumor Markers Among Patients With De Novo Metastatic Breast Cancer
    Di Meglio, Antonio
    Lin, Nancy U.
    Freedman, Rachel A.
    Barry, William T.
    Winer, Eric P.
    Vaz-Luis, Ines
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (03): : 316 - 324
  • [47] HER2 Evaluation in Relation to Breast Cancer Treatment Decisions in a Managed Care Plan
    Weinmann, S.
    Goddard, K. A. B.
    Richert-Boe, K. E.
    Chen, C.
    Bulkley, J. E.
    Wax, C.
    [J]. CANCER RESEARCH, 2010, 70
  • [48] Correlation of Circulating Tumor Cells (CTC) with Clinical Characteristics, Pathological Factors, and Treatment Response in Patients with Metastatic Breast Cancer (MBC)
    Bayable, Asnakech
    Wang, Tingchang
    Blackford, Amanda
    Tao, Jessica
    Canzoniero, Jenna
    Lee, Seoho
    Too, Faith
    Blouw, Barbara
    Wilkinson, Mary
    Couzi, Rima
    Wolff, Antonio
    Hiton, Christie
    Park, Ben
    Stearns, Vered
    Santa-Maria, Cesar
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [49] ETHNIC DISPARITIES IN METASTASIS PATTERNS AND TREATMENT UTILIZATION AMONG METASTATIC BREAST CANCER PATIENTS WITH BRAIN METASTASIS: A RETROSPECTIVE ANALYSIS OF US HEALTH SYSTEMS DATA (2019-2023)
    Podder, Vivek
    Ranjan, Tulika
    Bardhan, Mainak
    Jayram, Diya
    Mahtani, Reshma
    Ahluwalia, Manmeet Singh
    [J]. NEURO-ONCOLOGY, 2024, 26
  • [50] Treatment of metastatic breast cancer patients: What is the standard care of the patients?
    Watanabe, T
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (06) : 355 - 356
12345